Company Active LTD

Company profile

Philips Electronics UK Limited

Philips Electronics UK Limited is a UK company with status active founded in 1947 based in South East England.

CRN
00446897
Founded
1947
Age
78

Overview

Legal name
PHILIPS ELECTRONICS UK LIMITED
Region
South East England
Registered address
ASCENT 1
AEROSPACE BOULEVARD
FARNBOROUGH
ENGLAND
GU14 6XW
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller Controls 5
1
Company Active LTD
Philips Electronics UK Limited
CRN 00446897
2
Direct controller Active LTD
Philips U.K. Limited
CRN 01927665
3
Ultimate controller Active LTD
Reset54 Ltd
CRN 17001910

Company events

Reference milestones and recent Companies House filing stream events.

8 events
29 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

15 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

25 Sep
2024

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzQzNzE2NTMzOGFkaXF6a2N4

Published 29 Sep 2024 07:15

25 Sep
2024

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzQzNzE0ODc3MWFkaXF6a2N4

Published 28 Sep 2024 12:24

25 Sep
2024

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzQzNzE0ODUzMGFkaXF6a2N4

Published 28 Sep 2024 12:22

19 Dec
1947

Incorporated

Inception

Company registered at Companies House

Public funding

10 awards
First funded
2006
Funded years
2006, 2008, 2009, 2012, 2013, 2014, 2015, 2019, 2020
Age at first award
58 years

Projects

2020 Collaborative R&D

Connected Communities for Healthy Ageing

1 Jun 2020 to 31 Oct 2020

Awarded
£0
Total cost £0

The World Health Organization has recognised Greater Manchester as the UK's first age-friendly city-region. As our population ageing, we need to move faster to create and shape GM as a test bed and vibrant market place for innovators to develop and deploy their products and services to support residents in our communities and neighbourhoods. The Internati...

2019 Collaborative R&D

I-CAIRD: Industrial Centre for AI Research in Digital Diagnostics

1 Feb 2019 to 31 Mar 2023

Awarded
£0
Total cost £1,861,539

"iCAIRD will be a Scottish centre of excellence, centred at the Queen Elizabeth University Hospital in Glasgow but with sites across Scotland, to enable joined up academic and commercial technology development and research, locally and nationally. Making use of the capability of modern computers to process the large amounts of data gathered in healthcare ...

2019 Collaborative R&D

PathLEAD: Pathology image data Lake for Education, Analytics and Discovery.

1 Jan 2019 to 31 Mar 2023

Awarded
£0
Total cost £4,179,870

"PathLEAD (**Path**ology data **L**akes, **E**ducation, **A**nalytics and **D**iscovery) is a consortium of nationally leading experts from the teaching hospitals of Coventry, Belfast, Nottingham and Oxford, their associated Universities and Philips, the commercial partner. We will develop computer aided diagnostics for testing of pathology samples. Speci...

2015 Feasibility Studies

Circular Economy Business Models for Medical Imaging and Ultrasound Equipment in the UK Healthcare Sector

1 Sep 2015 to 29 Feb 2016

Awarded
£6,181
Total cost £12,361

Currently circular economy business models are not common practice within the UK healthcare sector, yet many other countries have already benefited from a shift away from the traditional linear value chain. Axion will work with Philips, a world leader in the supply of medical imaging systems and therapy devices, to investigate how a circular economy busin...

2014 Collaborative R&D Lead participant

Atherosclerosis stratification using advanced imaging and computer-based models

1 Apr 2014 to 31 Dec 2017

Awarded
£162,981
Total cost £325,962

The goal of the proposed project is to develop a novel tool for atherosclerosis risk stratification. Cardiovascular disease (CVD) (especially, coronary artery disease and stroke) is the leading single cause of morbidity and mortality in the Western world. Vascular atherosclerotic disease is a causative factor in a high percentage of CVD events. Widely acc...

2013 Small Business Research Initiative Lead participant

Home-based monitoring for the early detection of severe neutropenia in patients receiving chemotherapy to enable intervention and avoidance of adverse events.

1 Oct 2013 to 30 Sep 2017

Awarded
£1,996,500
Total cost £1,996,500

This SBRI Phase II proposal is to establish the necessary knowledge from the planned clinical studies and economic modelling to prove that an innovative technology: home tele-monitoring using white blood cell (WBC) count point of care technology (POCT) can help improve the care pathway and patient experience of people with cancer patients on chemotherapy....

2012 Knowledge Transfer Partnership

University of Leeds And Philips Electronics (UK) Limited

1 Sep 2012 to 31 Mar 2015

Awarded
Unknown

To develop methods to link patient events and outcomes obtained from clinical datasets, to inform decision support rules and accelerate uptake of emerging diagnostic platforms.

2009 Collaborative R&D

Project Hydra

1 Oct 2009 to 30 Jun 2012

Awarded
£62,470
Total cost £124,939

Project Hydra is designed to bridge the gap between smart metering and telecare, exploring ways to utilise the same infrastructure and investment to deliver two key benefits to the UK population for a single cost. Governments globally are setting roll-out targets for smart meters, resulting in a new communications path to every home. In an innovative appr...

2008 Collaborative R&D Lead participant

Point of Care Blood Cell Analysis

1 Sep 2008 to 28 Feb 2013

Awarded
£364,661
Total cost £1,447,068

The Full Blood Count or FBC is a test that enumerates the different types of cells in a sample of blood and is probably the most commonly performed diagnostic test. We are developing a new platform technology that will enable the FBC to be performed at the Point of Care (PoC). A new generation of low-cost, high technology health monitoring and diagnostic ...

2006 Collaborative R&D

SAPHE: Smart and Aware Pervasive Healthcare Environment

1 Mar 2006 to 31 Oct 2009

Awarded
£243,086
Total cost £1,063,810

Awaiting Public Summary

Product types

Collaborative R&D Feasibility Studies Knowledge Transfer Partnership Small Business Research Initiative